grants_govRFA-HG-27-013
Open
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
- Response deadline
- Oct 30, 2026 Due in 58 days
- Date posted
- Jun 18, 2026
- Source
- Open notice
Description
The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. This Notice of Funding Opportunity is intended to stimulate the development and testing of highly innovative experimental or computational approaches for rare disease diagnosis, that have the potential to make transformative improvements to the current state of the art.
Classifications
- NAICS93.172
Documents (1)
- DownloadRFA-HG-27-013-Full-Announcement.htmltext/html;charset=UTF-8143 KB
Contacts
Similar contracts
- GREGoRi Technology Integration Center (U01, Clinical Trials Optional)Due Oct 30, 2026
- GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)Due Oct 30, 2026
- NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed)Due May 5, 2029
- NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed)Due May 25, 2029
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)Due Nov 30, 2028
- Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)Due Feb 26, 2027